Pharmacological study of a new substance, mecinarone
Pourrias, B.; Sergant, M.; Thomas, J.; Gouret, C.; Raynaud, G.
Arzneimittel-Forschung 25(5): 782-786
1975
ISSN/ISBN: 0004-4172 PMID: 1242324 Document Number: 89764
Mecinarone, a benzofuranic chalcone, shows considerable vasodilating activity on the peripheral and cerebral circulation. The intramuscular irrigation is thus improved and the cerebral blood supply increased. This vasodilating activity is accompanied by only a slight drop in the systemic arterial pressure and occurs without cardiac depression. Mecinarone has also antibradykinin, antiserotonin and antiaggregation properties which added to the vasodilating activity, greatly increase its pharmacological interest.
Document emailed within 1 workday
Related Documents
Landheim, A.S.; Bakken, K.; Vaglum, P. 2006: What characterizes substance abusers who commit suicide attempts? Factors related to Axis i disorders and patterns of substance use disorders. a study of treatment-seeking substance abusers in Norway European Addiction Research 12(2): 102-108Shoji, M.; Harigaya, Y.; Okamoto, K.; Yamaguchi, H.; Hirai, S. 1988: The study of neuroactive substance within senile plaques--with special reference to somatostatin and substance P Rinsho Shinkeigaku 28(1): 67-73
Gogerty, J.H.; Penberthy, C.; Iorio, L.C.; Trapold, J.H. 1975: Pharmacological analysis of a new anorexic substance: 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo-(2, 1-a) isoindole (Mazindol) Archives Internationales de Pharmacodynamie et de Therapie 214(2): 285-307
Hylden, J.L.; Wilcox, G.L. 1983: Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level Journal of Pharmacology and Experimental Therapeutics 226(2): 398-404
Hojo, M.; Nagasaka, Y.; Katayama, O.; Serizawa, I. 1981: Pharmacological study of Mequitazine (LM-209). (V). Pharmacological actions of a main metabolite of LM-209, mequitazine sulfoxide (LM-209 SO) Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 78(5): 431-438
Pedersen, J.M. 1994: Substance abuse among school children in Greenland in 1992. a nation-wide follow-up study of substance abuse habits among school children Ugeskrift for Laeger 156(27): 4036-4038
Browne, F.A.; Wechsberg, W.M. 2010: The intersecting risks of substance use and HIV risk among substance-using South African men and women Current Opinion in Psychiatry 23(3): 205-209
Farmer, R.F.; Kosty, D.B.; Seeley, J.R.; Gau, J.M.; Klein, D.N. 2019: Family Aggregation of Substance use Disorders: Substance Specific, Nonspecific, and Intrafamilial Sources of Risk Journal of Studies on Alcohol and Drugs 80(4): 462-471
Floyd, L.J.; Hedden, S.; Lawson, A.; Salama, C.; Moleko, A.Gloria.; Latimer, W. 2010: The association between poly-substance use, coping, and sex trade among black South African substance users Substance use and Misuse 45(12): 1971-1987
Whitesell, N.Rumbaugh.; Beals, J.; Mitchell, C.M.; Manson, S.M.; Turner, R.Jay.; Big Crow, C.K.; Buchwald, D.; Chambers, B.; Christensen, M.L.; Dillard, D.A.; DuBray, K.; Espinoza, P.A.; Fleming, C.M.; Wilson Frederick, A.; Gone, J.; Gurley, D.; Jervis, L.L.; Jim, S.M.; Kaufman, C.E.; Klein, S.A.; Lee, D.; Manson, S.M.; McNulty, M.C.; Middlebrook, D.L.; Moore, L.A.; Nez, T.D.; Norton, I.M.; Novins, D.K.; O'Nell, T.; Orton, H.D.; Randall, C.J.; Sam, A.; Shore, J.H.; Simpson, S.G.; Yazzie, L. 2009: Childhood exposure to adversity and risk of substance-use disorder in two American Indian populations: the meditational role of early substance-use initiation Journal of studies on alcohol and drugs 70(6): 971-981
Vandel, B.; Vandel, S.; Magnin, P. 1970: Pharmacological interest of the study of cellular metabolic changes of the central nervous system during convulsions. I. Study of the technical conditions in rats Therapie 25(1): 173-180
Baudet, M.F.; Delplanque, B.; Beaumont, J.L. 1977: Immunochemical study of the lipoprotein substance Pg Pathologie-Biologie 25(5): 333-340
Fisun, A.I.; Kuvshinov, K.É; Shamreĭ, V.K.; Alekseev, V.V.; Goncharenko, A.I.; Pastushenkov, A.V.; Tikhenko, V.V. 2014: Prophylaxis of substance abuse in the Armed Forces: organization and performance of screening. Problem of substance dependence disorders is the actual for many countries in the world and affects on health of servicemen Voenno-Meditsinskii Zhurnal 335(3): 4-12
Harenberg, J.; Hengen, N.; Spohr, U.; Weber, E.; Pollter, J.; Schnitker, J. 1979: Pharmacological study on treptilamine in man/study on tolerability Arzneimittel-Forschung 29(8): 1189-1192
Jia, K. 1995: The study of somatotrophic substance for hepatic cells Zhonghua Nei Ke Za Zhi 34(4): 219-220
Barnea, Z.; Rahav, G.; Teichman, M. 1987: The reliability and consistency of self-reports on substance use in a longitudinal study British Journal of Addiction 82(8): 891-898
1999: Center for Mental Health Services; Center for Substance Abuse Treatment; fiscal year 1999 funding opportunity. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services (CMHS), Center for Substance Abuse Treatment (CSAT). Notice of availability of funds for cooperative agreements for CMHS/CSAT collaborative program on homeless families: women with psychiatric, substance u Federal register 64(108): 30350-30352
Velázquez, R.A.; Kitto, K.F.; Larson, A.A. 1997: CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse Journal of Pharmacology and Experimental Therapeutics 281(3): 1231-1237
Okamoto, Y.; Shirotori, K.; Kudo, K.; Ishikawa, K.; Ito, E.; Togawa, K.; Saito, I. 1993: Cytokine expression after the topical administration of substance P to human nasal mucosa. the role of substance P in nasal allergy Journal of Immunology 151(8): 4391-4398
1990: American Academy of Pediatrics Provisional Committee on Substance Abuse: Selection of substance abuse treatment programs Pediatrics 86(1): 139-140